UNSPSC 51152032: Hexcarbacholine

This classification denotes a muscle relaxant with the molecular formula C18H40N4O4.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NM87THP11P, chemically known as n,n,n,n,n,n-hexamethyl-4,13-dioxo-3,14-dioxa-5,12-diazahexadecamethylendiammonium dibromid but generally known as hexcarbacholine bromide, which bears US NIH Compound Identifier 71495. European Medicines Agency schedules Hexcarbacholine bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08034MIG.

The term HEXCARBACHOLINE BROMIDE is an International Non-Proprietary Name. As of Q4 2014, HEXCARBACHOLINE remains the US FDA Preferred Term for this commodity. Hexcarbacholine bears US NLM identifiers UMLS ID C2828259 and NCI Concept Code C87312. SMILES: Br. Br.O(CC[N](C)(C)C)C(=O)NCCCCCCNC(=O)OCC[N](C)(C)C.

UNSPSC 51152032 Hexcarbacholine, a Commodity code, shows minimal recent activity in state and local procurement that aligns with its nominal scope. The two most recent opportunities posted under this code involve naloxone procurement and direct-to-manufacturer prescription programs—neither of which is hexcarbacholine. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct relationships between the state's pharmacy benefit program and manufacturers. Neither opportunity represents procurement of hexcarbacholine itself.

The geographic spread of recent activity is limited to Florida and Texas, with no evidence of broader state or local demand for hexcarbacholine. The issuing bodies represent a health department (Texas HHS) and a county health function (Seminole County), suggesting that any hexcarbacholine demand, if present, would likely emerge from state health agencies or county public health departments rather than municipalities or school districts. The code exhibits little signal of active procurement interest at the state or local level, and the opportunities posted under it appear to reflect tagging mismatches rather than genuine market activity for hexcarbacholine as a commodity.